San Diego, CA -- (SBWIRE) -- 09/15/2016 -- An investigation on behalf of current long-term investors in shares of Sientra Inc (NASDAQ:SIEN) was announced over potential breaches of fiduciary duties by certain officers and directors at Sientra Inc.

Investors who purchased shares of Sientra Inc (NASDAQ:SIEN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain Sientra Inc (NASDAQ:SIEN officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

On September 24, 2015, it was announced that the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) had suspended sales of Sientra's Silimed-brand silicone breast implants following the discovery of contamination in the company's Rio De Janeiro manufacturing plant.

Shares of Sientra Inc (NASDAQ:SIEN) declined from $24.44 per share on September 16, 2015 to as low as $9.60 per share on September 24, 2015.

On September 25, 2015 a lawsuit was filed against Sientra Inc (NASDAQ:SIEN) Federal Securities violations. The plaintiff claims that between March 18, 2015 and September 24, 2015 Defendants made allegedly false and/or misleading statements and/or allegedly failed to disclose that Sientra Inc's exclusive reliance on Silimed's Brazilian manufacturing facilities carried significant quality control risks, that the manufacturing processes at the Silimed Rio de Janeiro manufacturing plant were contaminated, and that as a result of the above, Sientra Inc's statements regarding quality control and other financial statements were materially false and misleading at all relevant times.

Those who purchased shares of Sientra Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com